• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾性骨营养不良:名称有何含义?介绍一种用于解释骨组织学发现的临床实用新模型。

Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings.

作者信息

Malluche H H, Monier-Faugere M C

机构信息

Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky, Lexington, KY, USA.

出版信息

Clin Nephrol. 2006 Apr;65(4):235-42. doi: 10.5414/cnp65235.

DOI:10.5414/cnp65235
PMID:16629221
Abstract

Renal osteodystrophy begins early in the course of chronic kidney disease and occurs almost without exception in all patients with Stage 5 disease (CKD-5). Bone biopsies and evaluation of mineralized bone sections after double tetracycline-labeling are currently considered the gold standard for diagnosis and classification of renal osteodystrophy. Nevertheless, bone biopsies are rarely employed. This is, at least in part, related to the paucity of nephrologists trained in performance of the procedure and the fact that reports of the histologic results are not easily translatable to clinical practice. Results are usually given qualitatively, using non-uniform classifications or by histomorphometric evaluations which are esoteric to most nephrologists. We suggest here that histomorphometric evaluation can be reserved for research and special situations. Also, the customarily used qualitative classification should be replaced by a clinically useful nomenclature, provided the interpretation is done by an individual with sufficient experience in bone pathology. We present a new interactive nomenclature for renal osteodystrophy that addresses abnormalities of turnover, abnormalities of bone balance, and abnormalities of mineralization. The new nomenclature, thus, includes disorders of high- and low-turnover with consideration of the interrelation with positive or negative bone balance with or without mineralization defect. In this schema, changes in bone status are described as deviations from a norm, and treatment is geared toward normalizing values rather than creating any absolute change in one direction or another. It is hoped that such a classification will be easily usable, clinically more relevant, and more amenable to individualized treatment guidance.

摘要

肾性骨营养不良在慢性肾脏病病程早期即开始出现,几乎所有5期疾病(CKD-5)患者均无一例外会发生。目前,双四环素标记后进行骨活检及矿化骨切片评估被认为是肾性骨营养不良诊断和分类的金标准。然而,骨活检很少被采用。这至少部分与缺乏接受过该操作培训的肾病学家以及组织学结果报告不易转化为临床实践这一事实有关。结果通常采用定性方式给出,使用的分类不统一,或者通过大多数肾病学家难以理解的组织形态计量学评估给出。我们在此建议,组织形态计量学评估可保留用于研究和特殊情况。此外,习惯使用的定性分类应由一种对临床有用的命名法取代,前提是由在骨病理学方面有足够经验的个人进行解读。我们提出了一种用于肾性骨营养不良的新的交互式命名法,该命名法涉及骨转换异常、骨平衡异常和矿化异常。因此,新的命名法包括高转换和低转换疾病,并考虑到与正性或负性骨平衡以及有无矿化缺陷的相互关系。在这个模式中,骨状态的变化被描述为与正常状态的偏差,治疗旨在使各项数值正常化,而不是在某一个方向上产生任何绝对变化。希望这样的分类易于使用、在临床上更具相关性,并且更适合个体化治疗指导。

相似文献

1
Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings.肾性骨营养不良:名称有何含义?介绍一种用于解释骨组织学发现的临床实用新模型。
Clin Nephrol. 2006 Apr;65(4):235-42. doi: 10.5414/cnp65235.
2
The relevance of mineralization lag time in the evaluation of histologic changes in renal osteodystrophy.矿化延迟时间在评估肾性骨营养不良组织学变化中的相关性。
Clin Nephrol. 1993 Apr;39(4):214-23.
3
Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate.骨组织形态计量学在肾性骨营养不良中的应用:利用碳酸镧前瞻性研究数据展示一种新方法
Clin Nephrol. 2005 Feb;63(2):138-45. doi: 10.5414/cnp63138.
4
Update on the role of bone biopsy in the management of patients with CKD-MBD.慢性肾脏病-矿物质和骨代谢异常患者骨活检在管理中的作用更新。
J Nephrol. 2017 Oct;30(5):645-652. doi: 10.1007/s40620-017-0424-8. Epub 2017 Aug 22.
5
Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.新千年第一个十年的肾性骨营养不良:对黑人和白人患者 630 例骨活检的分析。
J Bone Miner Res. 2011 Jun;26(6):1368-76. doi: 10.1002/jbmr.309.
6
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).肾性骨营养不良的定义、评估及分类:改善全球肾脏病预后组织(KDIGO)的立场声明
Kidney Int. 2006 Jun;69(11):1945-53. doi: 10.1038/sj.ki.5000414.
7
The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.骨活检在肾性骨营养不良诊断中的作用:简要概述与未来展望。
J Nephrol. 2016 Oct;29(5):617-26. doi: 10.1007/s40620-016-0339-9. Epub 2016 Jul 29.
8
Role of bone biopsy in renal osteodystrophy.骨活检在肾性骨营养不良中的作用。
Saudi J Kidney Dis Transpl. 2009 Jan;20(1):12-9.
9
Bone histomorphometry in renal osteodystrophy.肾性骨营养不良的骨组织形态计量学
Semin Nephrol. 2009 Mar;29(2):122-32. doi: 10.1016/j.semnephrol.2009.01.005.
10
Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.慢性肾脏病3 - 5期患者的骨组织形态计量学及骨转换生化标志物
Clin Nephrol. 2008 Oct;70(4):296-305. doi: 10.5414/cnp70296.

引用本文的文献

1
Retrospective Characterization of Bone Histomorphometric Findings in Clinical Patient Specimens.临床患者标本骨组织形态计量学结果的回顾性特征分析
J Bone Metab. 2024 May;31(2):132-139. doi: 10.11005/jbm.2024.31.2.132. Epub 2024 May 31.
2
Fracture Risk Among Living Kidney Donors 25 Years After Donation.供肾者捐赠后 25 年的骨折风险
JAMA Netw Open. 2024 Jan 2;7(1):e2353005. doi: 10.1001/jamanetworkopen.2023.53005.
3
Renal osteodystrophy: something old, something new, something needed.肾性骨营养不良:旧的、新的、需要的。
Curr Opin Nephrol Hypertens. 2023 Nov 1;32(6):559-564. doi: 10.1097/MNH.0000000000000918. Epub 2023 Aug 8.
4
Review on the protective activity of osthole against the pathogenesis of osteoporosis.蛇床子素对骨质疏松症发病机制的保护作用综述
Front Pharmacol. 2023 Aug 23;14:1236893. doi: 10.3389/fphar.2023.1236893. eCollection 2023.
5
FGF-23 and sclerostin in serum and bone of CKD patients.血清和骨组织中 CKD 患者的 FGF-23 和 Sclerostin。
Clin Nephrol. 2023 May;99(5):209-218. doi: 10.5414/CN111111.
6
Is Adynamic Bone Always a Disease? Lessons from Patients with Chronic Kidney Disease.骨动力不足就一定是疾病吗?来自慢性肾病患者的经验教训。
J Clin Med. 2022 Nov 30;11(23):7130. doi: 10.3390/jcm11237130.
7
Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD.轻至中度慢性肾脏病患者中具有异常骨质量和血管钙化的低转换型肾性骨营养不良
Kidney Int Rep. 2022 Mar 6;7(5):1016-1026. doi: 10.1016/j.ekir.2022.02.022. eCollection 2022 May.
8
Secondary Osteoporosis and Metabolic Bone Diseases.继发性骨质疏松症和代谢性骨病
J Clin Med. 2022 Apr 24;11(9):2382. doi: 10.3390/jcm11092382.
9
Bone volume, mineral density, and fracture risk after kidney transplantation.肾移植后骨量、骨密度和骨折风险。
PLoS One. 2022 Mar 29;17(3):e0261686. doi: 10.1371/journal.pone.0261686. eCollection 2022.
10
Clinical Prediction of High-Turnover Bone Disease After Kidney Transplantation.肾移植后高转换性骨病的临床预测。
Calcif Tissue Int. 2022 Mar;110(3):324-333. doi: 10.1007/s00223-021-00917-1. Epub 2021 Oct 19.